Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Psychological Reports
|
December 1, 1972
Psychological test scores for a group of MEDEX trainees
L A Stone, G R Bassett, J D Brosseau, et al.
Neurology
|
April 1, 1997
Clinical safety of serial monthly administrations of gadopentetate dimeglumine in patients with multiple sclerosis: implications for natural history and early-phase treatment trials
R M Tresley, L A Stone, N Fields, et al.
AJNR. American Journal of Neuroradiology
|
March 16, 2013
Sensorimotor cortex gamma-aminobutyric acid concentration correlates with impaired performance in patients with MS
P K Bhattacharyya, M D Phillips, L A Stone, et al.
Neurology
|
April 2, 1999
A safety and pharmacokinetic study of intravenous natalizumab in patients with MS
W A Sheremata, T L Vollmer, L A Stone, et al.
Neurology
|
May 1, 1997
Interferon beta results in immediate reduction of contrast-enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI
P A Calabresi, L A Stone, C N Bash, et al.
Perceptual and Motor Skills
|
April 1, 1973
Training staffs multidimensional perceptions of a class of Medex (physician's extension) trainees: a method of grading
L A Stone, G R Bassett, J D Brosseau, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 1, 1996
MRI studies of multiple sclerosis: implications for the natural history of the disease and for monitoring effectiveness of experimental therapies
H F McFarland, L A Stone, P A Calabresi, et al.
Annals of Neurology
|
January 1, 1994
Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing-remitting multiple sclerosis: implications for treatment trials
J A Frank, L A Stone, M E Smith, et al.
Annals of Neurology
|
May 1, 1995
The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis
L A Stone, J A Frank, P S Albert, et al.
Neurology
|
June 1, 1995
Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age
L A Stone, M E Smith, P S Albert, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Psychological Reports
|
December 1, 1972
Psychological test scores for a group of MEDEX trainees
L A Stone, G R Bassett, J D Brosseau, et al.
Neurology
|
April 1, 1997
Clinical safety of serial monthly administrations of gadopentetate dimeglumine in patients with multiple sclerosis: implications for natural history and early-phase treatment trials
R M Tresley, L A Stone, N Fields, et al.
AJNR. American Journal of Neuroradiology
|
March 16, 2013
Sensorimotor cortex gamma-aminobutyric acid concentration correlates with impaired performance in patients with MS
P K Bhattacharyya, M D Phillips, L A Stone, et al.
Neurology
|
April 2, 1999
A safety and pharmacokinetic study of intravenous natalizumab in patients with MS
W A Sheremata, T L Vollmer, L A Stone, et al.
Neurology
|
May 1, 1997
Interferon beta results in immediate reduction of contrast-enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI
P A Calabresi, L A Stone, C N Bash, et al.
Perceptual and Motor Skills
|
April 1, 1973
Training staffs multidimensional perceptions of a class of Medex (physician's extension) trainees: a method of grading
L A Stone, G R Bassett, J D Brosseau, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 1, 1996
MRI studies of multiple sclerosis: implications for the natural history of the disease and for monitoring effectiveness of experimental therapies
H F McFarland, L A Stone, P A Calabresi, et al.
Annals of Neurology
|
January 1, 1994
Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing-remitting multiple sclerosis: implications for treatment trials
J A Frank, L A Stone, M E Smith, et al.
Annals of Neurology
|
May 1, 1995
The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis
L A Stone, J A Frank, P S Albert, et al.
Neurology
|
June 1, 1995
Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age
L A Stone, M E Smith, P S Albert, et al.
Page
of 5